Summary:
Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at DERMATOLOGY GROUP OF FLORIDA, PA on March 13, 2026. The laboratory was surveyed under 42 CFR Part 493 CLIA requirements. Standard deficiency cited as follows: D5805 TEST REPORT CFR(s): 493.1291(c) (c) The test report must indicate the following: (c)(1) For positive patient identification, either the patient's name and identification number, or a unique patient identifier and identification number. (c)(2) The name and address of the laboratory location where the test was performed. (c)(3) The test report date. (c)(4) The test performed. (c)(5) Specimen source, when appropriate. (c)(6) The test result and, if applicable, the units of measurement or interpretation, or both. (c)(7) Any information regarding the condition and disposition of specimens that do not meet the laboratory's criteria for acceptability. This STANDARD is not met as evidenced by: Based on record review and staff interview, the laboratory report failed to list the correct laboratory name in the final report for one out of five patients reviewed from October 2024 to March 2026 for the Histopathology Hematoxylin and Eosin stained slides for Frozen section tissue. Findings Included: 1-Review of five patient reports for in the following dates: Patient #1 (P#1) (10/01/2024), P#2 (12/03/2024), P#3 (04 /08/2025) P#4 (10/10/2025) and P#5 (02/24/2026), revealed that the report for P #4 failed to include the correct laboratory name. 2-During an interview on 03/13/2026 at 12:30 PM, the Risk Management representative confirmed that the report for P#4 failed to include the correct name of the laboratory that performed the Histopathology Hematoxylin and Eosin stained slide for Frozen sections. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --